申请人:BAYER PHARMA AKTIENGESELLSCHAFT
公开号:US20160297771A1
公开(公告)日:2016-10-13
The present application relates to novel substituted uracil derivatives of formula (I), to a method for the production thereof, to the use thereof either alone or in combination for treating and/or preventing diseases, and to the use thereof for producing pharmaceuticals for the treatment and/or prevention of diseases.
本申请涉及式(I)的新颖取代尿嘧啶衍生物,以及其生产方法,单独或结合使用于治疗和/或预防疾病,以及用于生产治疗和/或预防疾病的药物的用途。